Search research articles
Contact Us
Filters
Showing results (31-40 of 46) with videos related to
Page
of 5
Sort By:
Cancer
|
July 1, 1995
European randomized study of screening for prostate cancer. Progress report of Antwerp and Rotterdam pilot studies
F H Schröder, L J Denis, W Kirkels, et al.
The Prostate
|
June 8, 2001
Why phase III trials of maximal androgen blockade versus castration in M1 prostate cancer rarely show statistically significant differences
L Collette, U E Studer, F H Schröder, et al.
The Prostate
|
July 1, 1999
Finasteride in association with either flutamide or goserelin as combination hormonal therapy in patients with stage M1 carcinoma of the prostate gland. International Prostate Health Council (IPHC) Trial Study Group
R Kirby, C Robertson, A Turkes, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 1, 1990
Suramin for prostatic cancer: a phase I/II study in advanced extensively pretreated disease
A T Van Oosterom, E A De Smedt, L J Denis, et al.
Scandinavian Journal of Urology and Nephrology. Supplementum
|
January 1, 1994
The TNM system of 1992. Comments from the TNM working group. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993
G D Chisholm, P O Hedlund, J Adolfsson, et al.
Urology
|
August 1, 1993
Goserelin acetate and flutamide versus bilateral orchiectomy: a phase III EORTC trial (30853). EORTC GU Group and EORTC Data Center
L J Denis, J L Carnelro de Moura, A Bono, et al.
The Prostate
|
February 11, 1999
Quality-adjusted survival (Q-TWiST) analysis of EORTC trial 30853: comparing goserelin acetate and flutamide with bilateral orchiectomy in patients with metastatic prostate cancer. European Organization for Research and Treatment of Cancer
I Rosendahl, G M Kiebert, D Curran, et al.
European Urology
|
March 31, 1998
Maximal androgen blockade: final analysis of EORTC phase III trial 30853. EORTC Genito-Urinary Tract Cancer Cooperative Group and the EORTC Data Center
L J Denis, F Keuppens, P H Smith, et al.
Urologic Oncology
|
January 14, 2011
Tumor, nodes, metastasis (TNM) classification of bladder cancer
J P Richie, A Bono, L J Denis, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1983
Early adjuvant adriamycin in superficial bladder carcinoma
C C Schulman, L J Denis, W Oosterlinck, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 46) with videos related to
Sort By:
Page
of 5
Cancer
|
July 1, 1995
European randomized study of screening for prostate cancer. Progress report of Antwerp and Rotterdam pilot studies
F H Schröder, L J Denis, W Kirkels, et al.
The Prostate
|
June 8, 2001
Why phase III trials of maximal androgen blockade versus castration in M1 prostate cancer rarely show statistically significant differences
L Collette, U E Studer, F H Schröder, et al.
The Prostate
|
July 1, 1999
Finasteride in association with either flutamide or goserelin as combination hormonal therapy in patients with stage M1 carcinoma of the prostate gland. International Prostate Health Council (IPHC) Trial Study Group
R Kirby, C Robertson, A Turkes, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 1, 1990
Suramin for prostatic cancer: a phase I/II study in advanced extensively pretreated disease
A T Van Oosterom, E A De Smedt, L J Denis, et al.
Scandinavian Journal of Urology and Nephrology. Supplementum
|
January 1, 1994
The TNM system of 1992. Comments from the TNM working group. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993
G D Chisholm, P O Hedlund, J Adolfsson, et al.
Urology
|
August 1, 1993
Goserelin acetate and flutamide versus bilateral orchiectomy: a phase III EORTC trial (30853). EORTC GU Group and EORTC Data Center
L J Denis, J L Carnelro de Moura, A Bono, et al.
The Prostate
|
February 11, 1999
Quality-adjusted survival (Q-TWiST) analysis of EORTC trial 30853: comparing goserelin acetate and flutamide with bilateral orchiectomy in patients with metastatic prostate cancer. European Organization for Research and Treatment of Cancer
I Rosendahl, G M Kiebert, D Curran, et al.
European Urology
|
March 31, 1998
Maximal androgen blockade: final analysis of EORTC phase III trial 30853. EORTC Genito-Urinary Tract Cancer Cooperative Group and the EORTC Data Center
L J Denis, F Keuppens, P H Smith, et al.
Urologic Oncology
|
January 14, 2011
Tumor, nodes, metastasis (TNM) classification of bladder cancer
J P Richie, A Bono, L J Denis, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1983
Early adjuvant adriamycin in superficial bladder carcinoma
C C Schulman, L J Denis, W Oosterlinck, et al.
Page
of 5